RxDoctor Payments Data

Ramani Peruvemba, MD

Interventional Pain Medicine · Rockville, MDNPI 1619924701

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,283 of the $6,652 with a category attached, or 64.4%. 24 manufacturers reported payments, led by MML US, Inc. at 34.6% of the total.

$6,652in general payments, 2019–2025

Across 114 payments — averaging $58.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • MML US, Inc.$2K
  • Medtronic$1K
  • Pacira Pharmaceuticals Incorporated$964
  • Abbott$569
  • Globus Medical$269
  • Boston Scientific$222
  • plus $1K from 18 others

What the payments were for

  • Travel & lodging$2,36936%
  • Food & beverage$4,28364%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,652 in reported general payments places this provider in the 65th percentile of 56 interventional pain medicine providers in Maryland.

See all interventional pain medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$175,844
Medicare patients
386
Services billed
3,915

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MovantikNaloxegol Oxalate12$6,424
OxycontinOxycodone Hcl11$5,588
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen108$4,411
Gabapentin134$3,593
Lidocaine25$3,383
Oxycodone Hcl174$2,832
Morphine Sulfate ErMorphine Sulfate45$2,203
Fentanyl12$1,680
Hydromorphone Hcl47$1,004
Pregabalin32$896
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34$723
Celecoxib13$526
Cyclobenzaprine Hcl27$391
Tramadol Hcl45$391
Duloxetine Hcl37$341

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Rockville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →